Zenas BioPharma Inc. (ZBIO)
NASDAQ: ZBIO
· Real-Time Price · USD
16.82
0.06 (0.36%)
At close: Aug 15, 2025, 3:59 PM
17.00
1.07%
After-hours: Aug 15, 2025, 05:40 PM EDT
Zenas BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -177.01M | -162.76M | -156.99M | -128.97M | -54.76M | -45.83M | -37.12M | -31.53M | -67.14M | -38.09M | -18.99M |
Depreciation & Amortization | -831K | 127K | 137K | 134K | 124K | 118K | 113K | 108K | 82K | 53K | 25K |
Stock-Based Compensation | 19.77M | 15.26M | 10.82M | 6.46M | 4.62M | 3.75M | 3.5M | 2.65M | 1.65M | 976K | 289K |
Other Working Capital | 10.1M | -1.51M | 13.69M | 14.69M | 9.92M | 3.42M | -7.62M | -10.55M | -6.93M | -6.06M | 1.51M |
Other Non-Cash Items | -48K | 43K | 925K | 1.72M | 1.77M | 11.69M | 11.03M | 10.88M | 10.71M | 500K | 309K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 9.71M | 9.71M | 25.43M | 24.13M | 14.62M | 6.7M | -8.04M | -14.36M | -9.4M | -6.63M | 1.24M |
Operating Cash Flow | -148.41M | -137.62M | -119.67M | -96.52M | -33.62M | -23.57M | -30.53M | -32.26M | -64.1M | -43.19M | -17.13M |
Capital Expenditures | -92K | -127K | -131K | -74K | -74K | -39K | -17K | -1.07M | -1.07M | -1.07M | -1.07M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -235.33M | -108.78M | -9.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 33.12M | 18.86M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -26.76M | -26.76M | -26.76M | -26.76M | n/a | n/a | n/a | -1M | -1M | -1M | -1M |
Investing Cash Flow | -229.06M | -116.8M | -30.55M | -26.83M | -74K | -39K | -17K | -1.07M | -1.07M | -1.07M | -1.07M |
Debt Repayment | n/a | n/a | n/a | n/a | 20M | 20M | 20M | 20M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.11M | -5.6M | -6.26M | -1.81M | -1.37M | -595K | 116K | 59.46M | 59.46M | 59.45M | 59.39M |
Financial Cash Flow | 237.65M | 413.67M | 412.96M | 411.15M | 197.18M | 19.45M | 20.12M | 79.46M | 59.46M | 59.45M | 59.39M |
Net Cash Flow | -140.01M | 159.31M | 262.89M | 287.73M | 163.47M | -4.04M | -10.35M | 46.31M | -5.54M | 15.2M | 41.21M |
Free Cash Flow | -148.5M | -137.75M | -119.81M | -96.59M | -33.69M | -23.61M | -30.55M | -33.33M | -65.18M | -44.26M | -18.2M |